Medical and Surgical Treatment of Esophageal Reflux

This study has been completed.

First Received: June 3, 2003 Last Updated: August 21, 2008 History of Changes

Sponsor:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT00061724

Purpose

The purpose of this project is to lay the groundwork for a proposed clinical trial to compare the effectiveness of two approaches to gastroesophageal reflux disease: treatment with medications and treatment with anti-reflux surgery. This project includes a non-interventional pilot study to test ways of measuring outcomes of treatment, and to gauge potential participants' willingness to enroll in the proposed clinical trial.

Condition
Gastroesophageal Reflux

Study Type:	Observational
Study Design:	Prospective

Resource links provided by NLM:

MedlinePlus related topics: Esophagus Disorders GERD Surgery

U.S. FDA Resources

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment:

175

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

age 18-80
diagnosis of gastroesophageal reflux disease
have taken proton pump inhibitor medications

Exclusion criteria:

prior esophageal surgery
other serious medical conditions

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00061724

Locations

United States, Illinois
Hines VA Medical Center
Maywood, Illinois, United States
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
United States, North Carolina
University of North Carolina
Chapel Hill, North Carolina, United States, 27599

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

More Information

No publications provided

Study ID Numbers:	MSTER
Study First Received:	June 3, 2003
Last Updated:	August 21, 2008
ClinicalTrials.gov Identifier:	NCT00061724 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Esophageal
Reflux

Additional relevant MeSH terms:

Deglutition Disorders
Esophageal Motility Disorders
Digestive System Diseases

Gastrointestinal Diseases
Esophageal Diseases
Gastroesophageal Reflux

ClinicalTrials.gov processed this record on November 05, 2009